Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home
Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide History

Nafarelin
Acetate

The breakthrough spray that made hormone therapy easier to take

Nafarelin is a man-made hormone delivered as a nasal spray that helps treat endometriosis and early puberty. Instead of injections, patients simply spray it in their nose twice a day. It works like leuprolide by stopping the body from making excess sex hormones, but the nasal delivery method was revolutionary. This was one of the first peptide drugs that could be given through the nose and still work powerfully in the body.

Scroll to Discover

Quick Facts

Nafarelin at a Glance

FDA approved and widely used for endometriosis and precocious puberty

1990

Discovery Year

When this peptide was first identified

Peptide

Type

Compound classification

FDA approved and widely used for endometriosis and precocious puberty

Status

Current regulatory status

Research compound

Primary Use

Main area of investigation

Injection

Administration

How this peptide is typically given

Peptide chain

Size

Molecular structure type

The Visionaries

Pioneers Who Dared
to Challenge the Impossible

Syntex Laboratories (now Roche), Palo Alto, CA

Syntex Laboratories

Developer and original manufacturer

Created nafarelin and pioneered intranasal peptide delivery under brand name Synarel

""

Roche (formerly Syntex/Roche), Basel, Switzerland

Roche Pharmaceutical Company

Current manufacturer (acquired Syntex)

Continues production and distribution of Synarel worldwide

""

Pfizer Inc., New York, NY

Pfizer

Distribution partner

Helps distribute and market nafarelin in multiple countries

""

The Journey

A Story of
Persistence & Triumph

The Discovery

A Peptide in the Nose

In the 1980s, researchers at Syntex faced a problem.

Key Moment

They had created a powerful hormone drug like leuprolide, but delivering it meant injections.

In the 1980s, researchers at Syntex faced a problem. They had created a powerful hormone drug like leuprolide, but delivering it meant injections. Most patients hated needles. Then someone had a wild idea: what if they put it in a nasal spray? Peptide hormones don't survive stomach acid, so the mouth was out. But the nose lining is special. It's moist and lined with blood vessels that absorb drugs quickly. Syntex tested nafarelin as a nasal spray. It worked. By 1990, the FDA approved it. Peptide drugs could now be given without needles.

The Breakthrough

Relief for Women in Pain

Endometriosis was a hidden epidemic affecting millions of women.

Key Moment

Endometriosis was a hidden epidemic affecting millions of women.

Endometriosis was a hidden epidemic affecting millions of women. Tissue that should line the uterus grows elsewhere in the body, causing severe pain. Before nafarelin, treatment options were limited and painful. Some women had surgery. Others took danazol pills that made them feel sick and changed their voice. Then nafarelin arrived. Women could spray it in their nose twice a day. Within weeks, the hormone levels dropped and the pain fell from unbearable to manageable. Severe pain reported by 40% of women dropped to just 5-10%. For many, nafarelin was a miracle.

The Trials

The Nasal Spray Innovation

The genius of nafarelin was not just the drug itself but how it was delivered.

Key Moment

The genius of nafarelin was not just the drug itself but how it was delivered.

The genius of nafarelin was not just the drug itself but how it was delivered. A small pump bottle dispensed exactly 200 micrograms per spray. Patients sprayed once in each nostril twice daily. The nose lining quickly absorbed the peptide into the bloodstream. This was revolutionary. Peptides are large molecules that usually require injection. Nafarelin proved that the right delivery method could get peptides through the body without needles. Scientists realized the nose could be a gateway for other peptide drugs too.

The Crisis

New Uses Emerge

Endometriosis was just the beginning.

Key Moment

Doctors found nafarelin helpful for another problem: children whose bodies started developing too early.

Endometriosis was just the beginning. Doctors found nafarelin helpful for another problem: children whose bodies started developing too early. Precocious puberty could stunt growth and cause emotional trauma. Parents wanted to pause puberty until children were older. Nafarelin did exactly that. A twice-daily nasal spray could hold back the hormone storm of puberty. Children could grow normally and develop emotionally before puberty began. Nafarelin opened new treatment options for pediatric medicine.

The Legacy

A Better Way to Take Medicine

Today, nafarelin remains one of only two nasal spray GnRH drugs in the world.

Key Moment

A spray in the nose proved just as powerful as an injection.

Today, nafarelin remains one of only two nasal spray GnRH drugs in the world. It showed the medical world that smart delivery methods matter as much as good drugs. Some patients still prefer injections. But many prefer a nasal spray to needles. Nafarelin taught doctors and patients that we can reimagine how to give medicine. A spray in the nose proved just as powerful as an injection. The innovation sparked research into more peptide nasal sprays and changed how we think about drug delivery.

Years of Progress

Timeline of
Breakthroughs

1988

Clinical trials show nafarelin spray equals oral danazol for endometriosis

Clinical trials show nafarelin spray equals oral danazol for endometriosis

1990

FDA approves Synarel nafarelin nasal spray

FDA approves Synarel nafarelin nasal spray

1990

First GnRH agonist approved as a nasal spray

First GnRH agonist approved as a nasal spray

1992

FDA approves nafarelin for central precocious puberty

FDA approves nafarelin for central precocious puberty

1995

Widespread adoption for endometriosis treatment across North America

Widespread adoption for endometriosis treatment across North America

2000

Available in Europe and most developed countries

Available in Europe and most developed countries

2005

Roche acquires Syntex and continues nafarelin production

Roche acquires Syntex and continues nafarelin production

2010

Nasal spray delivery method becomes gold standard for patient preference

Nasal spray delivery method becomes gold standard for patient preference

2015

Recognized as one of two nasal GnRH drugs available worldwide

Recognized as one of two nasal GnRH drugs available worldwide

2020

Continued use in endometriosis and precocious puberty treatment

Continued use in endometriosis and precocious puberty treatment

The Science

Understanding
the Mechanism

Nafarelin is a synthetic copy of gonadotropin-releasing hormone (GnRH), a natural hormone made in the brain. It works the same way as leuprolide: when continuously present, it shuts down sex hormone production. The difference is delivery. When injected daily or monthly, leuprolide requires needles. Nafarelin comes as a nasal spray. When you spray it in your nose, the lining absorbs it directly into the blood. The nasal mucosa is lined with tiny blood vessels and is specially designed to absorb molecules quickly. This makes nafarelin a peptide drug that works without injection, a major innovation in medicine.

Molecular Structure

C66H83N17O13

Molecular Formula

1322.5 g/mol

Molecular Weight

Ten amino acid peptide (a small protein chain)

Type

Modified GnRH with naphthyl side chain for enhanced activity

Structure

Global Impact

Transforming Lives
Across the World

1990

Year FDA approved nafarelin

Year FDA approved nafarelin, the first nasal spray GnRH drug

65%

Reduction in severe endometriosis

Reduction in severe endometriosis pain with nafarelin treatment

2

Number of nasal spray

Number of nasal spray GnRH drugs in the entire world

Worldwide

Available in North America

Available in North America, Europe, and most developed countries

Real Stories, Real Lives

Sarah

""

James

""

The Future of Nafarelin

Research Stage

More Nasal Peptide Drugs

Nafarelin proved peptides can work through the nose, inspiring research into other nasal peptide medications

Research Stage

Improved Absorption Technology

Scientists develop better nasal formulations to increase how much drug the body absorbs

Research Stage

Extended-Release Nasal Sprays

Working on sprays that work for a week or month instead of requiring twice-daily doses

Research Stage

Combination Nasal Therapies

Exploring nasal sprays that combine nafarelin with bone-protective or symptom-relieving drugs

Be Inspired

The story of Nafarelin is ultimately about the relentless pursuit of better medicine for humanity.

Continue the legacy. The next breakthrough could be yours.

Nafarelin Chronicles

Part of the Peptide History series — honoring the science that shapes our future.

© 2026 Peptide History. Educational content for research purposes.

This content is for educational purposes only and should not be considered medical advice.

Peptide Pro